Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Recruiting

Phase 1

Phase 2

SA53-OSSafety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Sponsor:

Lamassu Bio Inc

Code:

NCT06578624

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SA53-OS (phase 1)

SA53-OS (phase 2)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-24. This information was provided to ClinicalTrials.gov by Lamassu Bio Inc on 2025-06-05.